-
The International Vaccine Institute (IVI) is hosting its 21st international five-day vaccinology course at the SNU Faculty House Convention Center which will run through Friday this week.IVI's Director General, Dr. Jerome Kim, said the trainees had to focus on moving vaccines from “need” to “impact”
Bio
Marianne Chang
2022.09.26 16:52
-
A team of researchers at Seoul National University Bundang Hospital said they discovered that a thinner retinal nerve fiber layer (RNFL) was associated with a higher risk of cognitive impairment in a large cohort study.It is the first time in Korea that a local study identified the relationship betw
Bio
Marianne Chang
2022.09.26 11:17
-
Researchers of the Urology Department at Asan Medical Center (AMC) said they have discovered a way to improve symptoms caused by interstitial cystitis or bladder pain syndrome by administering mesenchymal stem cells derived from human embryonic stem cells.Interstitial cystitis, which is accompanied
Bio
Marianne Chang
2022.09.23 14:45
-
A Pakistani professor from a Swiss university said consanguineous marriages were the best resource to study recessive disorders because it is easier to identify new genes in this population.Muhammad Ansar from the University of Lausanne presented on the discovery of new recessive disease genes and t
Bio
Marianne Chang
2022.09.23 13:12
-
A team of researchers at Yonsei Severance Hospital said they discovered six key cardiovascular health (CVH) metrics to reduce dementia risk in a recent study.According to the World Health Organization (WHO), dementia is the deterioration in cognitive function which affects memory, thinking, orientat
Bio
Marianne Chang
2022.09.22 11:36
-
A joint research team from Korea Advanced Institute of Science and Technology (KAIST) said on Wednesday they developed a bio-friendly adhesive by mixing tannic acid with bio-compatible polymers to improve existing hair transplant methods.Tannic acid is a type of polyphenol found in fruit shells, nut
Bio
Marianne Chang
2022.09.21 16:07
-
The bio-medical industry, which was the largest investment destination for venture capital (VC) companies from 2018 to 2020, slumped to third place in the first half of this year.According to a report by the Biotech Policy Research Center, new VC investment in the bio-medical industry was 675.8 bill
Bio
Lee Han-soo
2022.09.20 15:32
-
ABL Bio will receive a short-term milestone of $20 million (27.8 billion won) from Sanofi.ABL Bio said in a public notice last Thursday that it would get $20 million in technical fees from Sanofi. The company explained that it was a milestone upon the completion of the non-clinical toxicity test (GL
Bio
Kim Chan-hyuk
2022.09.19 13:18
-
Celltrion said that the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Vegzelma, a biosimilar referencing Avastin (ingredient: bevacizumab), to treat various cancers.The company received full label approval for all of Avastin's indications, including metastatic colore
Bio
Lee Han-soo
2022.09.19 11:22
-
Prestige BioPharma said Thursday it has voluntarily withdrawn its European Medicines Agency (EMA) application for the re-examination of approving HD201 (brand name: Tuznue), a biosimilar referencing Herceptin to treat breast cancer and metastatic gastric cancer.The withdrawal comes after the company
Bio
Lee Han-soo
2022.09.16 13:25
-
Voronoi and U.S. bio company METiS Therapeutic have signed a contract to license out (L/O) kinase inhibitor technology worth 668 billion won ($482 million).In a public notice Wednesday, Voronoi said it had signed a technology transfer contract for phosphorylase inhibitors for oral use (kinase) for t
Bio
Kim Chan-hyuk
2022.09.15 15:56
-
HLB, a Korean biotech firm, said Tuesday it would submit a new drug application (NDA) to the FDA for marketing approval of an anticancer drug, rivoceranib, in early 2023.HLB said the FDA’s designation of camrelizumab, used in combination with rivoceranib, as an orphan drug would speed up the regulat
Bio
Kim Chan-hyuk
2022.09.14 11:14
-
The U.S. Food and Drug Administration recommended Golden Biotechnology Corp., a Taiwanese biopharmaceutical company, to conduct an additional clinical trial of antroquinonol, a Covid-19 treatment candidate, BNC Korea said.In August 2020, Golden Biotech and BNC Korea signed an agreement for the latte
Bio
Kim Chan-hyuk
2022.09.13 15:20
-
U.S. President Joe Biden on Monday signed an executive order implementing a new initiative aiming to boost biomanufacturing in pharmaceuticals.The initiative aims to help expand U.S. biomanufacturing capabilities and reduce reliance on China.According to people familiar with the matter, the order la
Bio
Lee Han-soo
2022.09.13 14:52
-
Despite the sluggish initial public offering (IPO) market continuing throughout the year, four Korean biotech companies are preparing to go public in September. The four companies are SunBio, RP Bio, Plasmapp, and Shaperon.Most biopharmaceutical companies that went public in the first half suffered
Bio
Lee Han-soo
2022.09.07 15:54
-
Helixmith has made public the topline data of the phase 2a clinical trial of Engensis (VM202), its genetic treatment candidate for amyotrophic lateral sclerosis (ALS).In a public notice last Friday, Helixmith said it had received the topline data of phase 2a trials of VM202 on patients from its cont
Bio
Kim Chan-hyuk
2022.09.05 14:16
-
HLB’s investigational anticancer drug, rivoceranib, proved the safety as a second-line treatment in gastric cancer in a phase 1 trial, according to an abstract partially released before the annual meeting of the European Society for Medical Oncology this Friday.The abstract includes results from a K
Bio
Kim Chan-hyuk
2022.09.05 14:14
-
The one-year grace period granted to Kolon TissueGene has ended. The securities authorities suspended the company’s stock transaction over the past year due to controversy over unwarranted ingredient change in Invossa, the world’s first osteoarthritis cell genetic treatment.In a public notice on Wed
Bio
Kim Chan-hyuk
2022.09.02 15:37
-
Eyegene Inc., which is developing messenger-RNA Covid-19 vaccine, said it would conduct clinical trials in the South African Republic, following Korea and Australia.In a public notice on Thursday, the company said it had won approval from SAHPRA, the South African Republic's health industry regulato
Bio
Kim Chan-hyuk
2022.09.02 13:12
-
AbClon, a Kosdaq-listed biotech firm, said it registered its technology patent related to chimeric antigen receptor (CAR)-T cell therapy in the U.S. and Canada, respectively.In the U.S., AbClon registered the patent on its switchable CAR-T platform technology, applicable in AT501 for ovarian cancer.
Bio
Kim Yoon-mi
2022.09.02 10:18
